Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer. Kelly RJ, Ajani JA, Kuzdzal J, Zander T, et al. N Engl J Med 2021;384:1191-1203.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kelly RJ, Ajani JA, Kuzdzal J, Zander T, et al. Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer. N Engl J Med 2021;384:1191-1203.
PMID: 33789008